Inside Patient21 Strategy
Patient21 has raised $187 million in total funding.
Subscribe: If this newsletter was forwarded to you, subscribe here.
“Digital health meets brick-and-mortar”
Patient21 is a five-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics.
The company has raised a total of $187 million in funding, with Pitango, Israel's largest venture capital fund, leading the Series C round of €100 million. This round saw participation from Bertelsmann Investments, Artian, and existing investors such as Target Global, Piton Capital, and PICO Venture Partners.
Patient21 is shaking up primary healthcare by blending advanced digital solutions with physical clinic operations, aiming for a seamless, patient-centered healthcare experience.
Its strategy lies in six pillars:
Digi-Physical Platform: They blend digital health services with physical clinics to create an integrated patient experience. This ensures patient records are always up-to-date and accessible, helping healthcare professionals make better decisions and provide higher quality care at lower costs
Focus: Their primary focus is on dentistry for now, with over 80% of its clinics targeting oral health. The rest are split between gynecology and general practice. Patient21 is committed to value-based healthcare, which emphasizes the quality of care provided to patients rather than the quantity of services rendered.
Technology: Patient21 has developed specialized software to manage patients and direct them to its 50-plus outpatient clinics across Germany. Additionally, they've created clinic-facing software that reduces administrative burdens for healthcare professionals, allowing them to prioritize patient care. This innovative approach effectively addresses staff shortages in the healthcare sector.
Data: The company leverages data to optimize healthcare delivery, ensuring patients get the best possible advice and treatment.
Expansion: Patient21 has seen significant growth, with more than 300,000 patient visits each year, now operating 50 clinics across 19 cities in Germany. The company employs 650 professionals in the dental field, enhancing its capacity to deliver high-quality healthcare services.
Strong Leadership: Christopher Muhr, former COO at Auto1 Group and co-founder of Citydeal (acquired by Groupon in 2010), along with Nicolas Hantzsch, who has led successful ventures like Veganz (IPO), MetaTravel/HometoGo (IPO), and Groupon (IPO), draw from their entrepreneurial journeys and personal battles with cancer. Their experiences drive their mission to innovate primary care through digital solutions at Patient21.
Looking Ahead: The founders believe there’s potential for partnerships or running clinics as franchises, providing franchisees with a unique combination of software and services.
+ Health-tech is good
👉 5 Takeaways from HLTH Europe 2024
Other topics you might find interesting 💡📍 8 Serial Entrepreneurs Building In Health-Tech & Bio-Tech in Europe.
👉 Click here to read the full article.
📍The $8.8 Billion DTC Genetic Testing Market
👉 Click here to read the full article.
Suggestion? Critiques? Send your feedback in this link or reply to this e-mail.
This newsletter can impact those around you. Feel free to share it.
